Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Electrophoresis|October 28, 2005
Multicapillary electrophoresis of unlabeled DNA fragments with high-sensitive laser-induced fluorescence detection by counter-current migration of intercalation dyeLucie Benesova-Minarikova, Lucie Fantova, Marek Minarik
Gastroenterology Research and Practice|May 12, 2015
MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and PrognosisTereza Halkova, Romana Cuperkova, Marek Minarik, et al.
Journal of Separation Science|June 25, 2010
Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapyLucie Benesova, Milos Pesek, Barbora Belsanova, et al.
Anticancer Research|July 2, 2010
Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitorsLucie Benesova, Marek Minarik, Dana Jancarikova, et al.
Electrophoresis|May 17, 2012
Rapid testing of clopidogrel resistance by genotyping of CYP2C19 and CYP2C9 polymorphisms using denaturing on-chip capillary electrophoresisMarek Minarik, Marta Kopeckova, Marcus Gassman, et al.
Forensic Science International. Genetics|March 11, 2010
Assembly of a large Y-STR haplotype database for the Czech population and investigation of its substructureJan Zastera, Lutz Roewer, Sascha Willuweit, et al.
Tumori|July 31, 2014
Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: a case reportOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Cancer Genetics|January 15, 2013
The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Anticancer Research|July 31, 2013
Sequential treatment of advanced-stage lung adenocarcinoma harboring wild-type EGFR gene: second-line pemetrexed followed by third-line erlotinib versus the reverse sequenceOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Anticancer Research|April 9, 2013
Gene mutations in squamous cell NSCLC: insignificance of EGFR, KRAS and PIK3CA mutations in prediction of EGFR-TKI treatment efficacyOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Pageof 5